Daewoong Pharmaceutical notified acquisition rumor of Daewoong Bio by European pharmaceutical company
On May 26, Daewoong Pharmaceutical notified acquisition rumor of Daewoong Bio by European pharmaceutical company, that "Daewoong Bio is reviewing overseas M & A target including Europe for the purpose of entering new market and expanding business sector. However, there is no specifically determin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.